In vivo assessment of inflammatory bowel disease in rats with ultrahigh-resolution colonoscopic OCT
- 15 March 2022
- journal article
- research article
- Published by Optica Publishing Group in Biomedical Optics Express
- Vol. 13 (4) , 2091-2102
Abstract
A technology capable of high-resolution, label-free imaging of subtle pathology in vivo during colonoscopy is imperative for the early detection of disease and the performance of accurate biopsies. While colonoscopic OCT has been developed to visualize colonic microstructures beyond the mucosal surface, its clinical potential remains limited by sub-optimal resolution (∼6.5 µm in tissue), inadequate imaging contrast, and a lack of high-resolution OCT criteria for lesion detection. In this study, we developed an ultrahigh-resolution (UHR) colonoscopic OCT and evaluated its ability to volumetrically visualize and identify the pathological features of inflammatory bowel disease (IBD) in a rat model. Owing to its improved resolution (∼1.7 µm in tissue) and enhanced contrast, UHR colonoscopic OCT can accurately delineate fine colonic microstructures and identify the pathophysiological characteristics of IBD in vivo. By using a quantitative optical attenuation map, UHR colonoscopic OCT is able to differentiate diseased tissue (such as crypt distortion and microabscess) from normal colonic mucosa over a large field of view in vivo. Our results suggest the clinical potential of UHR colonoscopic OCT for in vivo assessment of IBD pathology.Keywords
Funding Information
- National Institutes of Health (R01CA153023, R01HL121788)
- Wallace H. Coulter Foundation
This publication has 42 references indexed in Scilit:
- Characterizing optical properties of nano contrast agents by using cross-referencing OCT imagingBiomedical Optics Express, 2013
- Relevance of TNBS-Colitis in Rats: A Methodological Study with Endoscopic, Histologic and Transcriptomic Characterization and Correlation to IBDPLOS ONE, 2013
- Guidelines for the management of inflammatory bowel disease in adultsGut, 2011
- Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer modelWorld Journal of Gastroenterology, 2011
- Optical Coherence Tomography in Inflammatory Bowel Disease: Prospective Evaluation of 35 PatientsDiseases of the Colon & Rectum, 2008
- Three-dimensional endomicroscopy using optical coherence tomographyNature Photonics, 2007
- In vivo ultrahigh-resolution optical coherence tomography of mouse colon with an achromatized endoscopeJournal of Biomedical Optics, 2006
- Guidelines for the management of inflammatory bowel disease in adultsGut, 2004
- Optical coherence tomography for ultrahigh resolution in vivo imagingNature Biotechnology, 2003
- Criteria for the diagnosis of dysplasia by endoscopic optical coherence tomographyGastrointestinal Endoscopy, 2003